EP2900335A1 - Process for protecting the colour of a textile material with an oil-in-water emulsion containing a mixture of alkylpolyglycoside and fatty alcohol and an associative nonionic polyurethane polyether - Google Patents
Process for protecting the colour of a textile material with an oil-in-water emulsion containing a mixture of alkylpolyglycoside and fatty alcohol and an associative nonionic polyurethane polyetherInfo
- Publication number
- EP2900335A1 EP2900335A1 EP13756376.3A EP13756376A EP2900335A1 EP 2900335 A1 EP2900335 A1 EP 2900335A1 EP 13756376 A EP13756376 A EP 13756376A EP 2900335 A1 EP2900335 A1 EP 2900335A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- alcohol
- process according
- oil
- glucoside
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
- D06P5/00—Other features in dyeing or printing textiles, or dyeing leather, furs, or solid macromolecular substances in any form
- D06P5/02—After-treatment
- D06P5/04—After-treatment with organic compounds
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
- D06P1/00—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
- D06P1/44—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders
- D06P1/52—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders using compositions containing synthetic macromolecular substances
- D06P1/5264—Macromolecular compounds obtained otherwise than by reactions involving only unsaturated carbon-to-carbon bonds
- D06P1/5285—Polyurethanes; Polyurea; Polyguanides
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
- D06P1/00—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
- D06P1/44—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders
- D06P1/60—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders using compositions containing polyethers
- D06P1/607—Nitrogen-containing polyethers or their quaternary derivatives
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06P—DYEING OR PRINTING TEXTILES; DYEING LEATHER, FURS OR SOLID MACROMOLECULAR SUBSTANCES IN ANY FORM
- D06P1/00—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed
- D06P1/44—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders
- D06P1/64—General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed using insoluble pigments or auxiliary substances, e.g. binders using compositions containing low-molecular-weight organic compounds without sulfate or sulfonate groups
- D06P1/651—Compounds without nitrogen
- D06P1/65106—Oxygen-containing compounds
- D06P1/65118—Compounds containing hydroxyl groups
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M2200/00—Functionality of the treatment composition and/or properties imparted to the textile material
- D06M2200/25—Resistance to light or sun, i.e. protection of the textile itself as well as UV shielding materials or treatment compositions therefor; Anti-yellowing treatments
Definitions
- a second subject of the present invention is the use of a composition as defined above as an agent for reducing or eliminating the fading of the colour of a coloured textile material in contact with a composition comprising at least one antiperspirant active agent.
- antiperspirant products in topical application to control the flow of sweat, to reduce the sensation of moisture on the skin associated with human sweat, and to mask human sweat.
- antiperspirant composition Many different types have been described in the literature and have appeared on the market in forms such as gels, sticks, creams, roll-ons or aerosols.
- Patent applications WO 92/06778, WO 95/13863 and WO 98/47610 disclose emulsifying systems consisting of mixtures of alkylpolyglucosides and of fatty alcohols, for obtaining oil-in-water emulsions which may contain a very wide range of active agents and especially deodorant active agents.
- These glucolipid emulsifying agents have the advantage of being compatible in all types of fatty phase and also in strongly acidic aqueous media in particular comprising antiperspirant salts. They make it possible to obtain emulsions in a wide texture range, from richness to evanescence with variable, fluid or creamy consistencies.
- (B) at least a mixture comprising at least one alkylpolyglycoside whose alkyl chain is linear or branched and comprises from 12 to 22 carbon atoms and at least one linear or branched fatty alcohol containing from 12 to 22 carbon atoms;
- a first subject of the present invention is thus a process for protecting the colour of a coloured textile material, characterized in that at least one oil-in-water emulsion is applied to the surface of the said textile, this emulsion containing, in a cosmetically acceptable medium:
- a second subject of the present invention is the use of a composition as defined above as an agent for reducing or eliminating the fading of the colour of a coloured textile material in contact with a composition comprising at least one antiperspirant active agent.
- the hydrophobic group may be derived from a fatty alcohol, such as stearyl alcohol, dodecyl alcohol or decyl alcohol, or else from a polyalkylenated fatty alcohol, such as Steareth-100. It may also denote a hydrocarbon-based polymer, for instance polybutadiene.
- compositions in accordance with the invention comprise at least a mixture of: a) at least one alkylpolyglycoside in which the alkyl chain is linear or branched and comprises from 12 to 22 carbon atoms, and
- alkylpolyglycoside means an alkylmonosaccharide (degree of polymerization 1 ) or an alkylpolyglycoside (degree of polymerization greater than 1 ).
- the fatty alcohol/alkylpolyglycoside emulsifying mixture contains: (a) from 5% to 60% by weight of alkylpolyglycoside(s);
- R(O)(G) x in which the radical R is a linear or branched C12-C22 alkyl radical, G is a saccharide residue and x ranges from 1 to 5, preferably from 1 .05 to 2.5 and more preferentially from 1 .1 to 2.
- the saccharide residue may be chosen from glucose, dextrose, saccharose, fructose, galactose, maltose, maltotriose, lactose, cellobiose, mannose, ribose, dextran, talose, allose, xylose, levoglucan, cellulose and starch. More preferentially, the saccharide residue denotes glucose.
- each unit of the polysaccharide part of the alkylpolyglycoside may be in a or ⁇ isomer form, in L or D form, and the configuration of the saccharide residue may be of furanoside or pyranoside type.
- fatty alcohols that are to be used, alone or as mixtures, in combination with the alkylpolysaccharides in the emulsifying mixtures in accordance with the invention, they may be linear or branched fatty alcohols, of synthetic origin, or of natural origin, for instance alcohols derived from plant matter (coconut, palm kernel, palm, etc.) or animal matter (tallow, etc.). Needless to say, other long-chain alcohols may also be used, for instance ether alcohols or Guerbet alcohols. Finally, use may also be made of certain more or less long fractions of alcohols of natural origin, for instance coconut (C12 to C16) or tallow (C16 to Cis) or compounds of diol or cholesterol type.
- the fatty alcohol(s) used are chosen from those containing from 12 to 22 carbon atoms and even more preferentially from 12 to 18 carbon atoms.
- fatty alcohols that may be used in the context of the present invention, mention may be made especially of lauryl alcohol, cetyl alcohol, myristyl alcohol, stearyl alcohol, isostearyl alcohol, palmityl alcohol, oleyl alcohol, behenyl alcohol and arachidyl alcohol, which may thus be taken alone or as mixtures.
- a fatty alcohol and an alkylpolysaccharide whose alkyl part is identical to that of the selected fatty alcohol are known per se. They are described in patent applications WO 92/06778, WO 95/13863 and WO 98/47610 and prepared according to the preparation processes indicated in those documents.
- fatty alcohol/alkylpolyglycoside mixtures that are particularly preferred, mention may be made of the products sold by the company SEPPIC under the name Montanov® or Fluidanov®, such as the following mixtures:
- the preferred fatty alcohol/alkylpolyglycoside mixtures will be chosen from cetylstearyl alcohol/cetylstearyl glucoside;
- nonionic polyurethane polyethers comprising a hydrophobic chain are those in which the hydrophilic blocks are linked to the hydrophobic blocks via other chemical bonds.
- a polyurethane polyether that may be obtained by polycondensation of at least three compounds comprising (i) at least one polyethylene glycol comprising from 150 to 180 mol of ethylene oxide, (ii) stearyl alcohol or decyl alcohol, and (iii) at least one diisocyanate.
- polyurethane polyethers are sold in particular by the company Rohm & Haas under the names Aculyn 46® and Aculyn 44®.
- Aculyn 46® having the INCI name: PEG-150/Stearyl Alcohol/SMDI Copolymer is a polycondensate of polyethylene glycol comprising 150 or 180 mol of ethylene oxide, of stearyl alcohol and of methyenebis(4-cyclohexyl isocyanate) (SMDI) at 15% by weight in a matrix of maltodextrin (4%) and water (81 %).
- a polyurethane polyether that may be obtained by polycondensation of at least three compounds comprising (i) at least one polyethylene glycol comprising from 150 to 180 mol of ethylene oxide, (ii) a polyoxyethylenated stearyl alcohol comprising 100 mol of ethylene oxide, and (iii) a diisocyanate.
- compositions may contain at least one antiperspirant active agent.
- antiperspirant active agents or astringents. They are preferably chosen from aluminium and/or zirconium salts; complexes of zirconium hydroxychloride and of aluminium hydroxychloride with an amino acid, such as those described in patent US-3 792 068, commonly known as "ZAG complexes". Such complexes are generally known under the name ZAG (when the amino acid is glycine). ZAG complexes ordinarily have an Al/Zr ratio ranging from about 1 .67 to 12.5 and a metal/CI ratio ranging from about 0.73 to 1 .93.
- the deodorant active agents may also be bacteriostatic agents or bactericidal agents 2,4,4'-trichloro-2'-hydroxydiphenyl ether (Triclosan®), 2,4-dichloro-2'- hydroxydiphenyl ether, 3',4',5'-trichlorosalicylanilide, 1 -(3',4'-dichlorophenyl)-3-(4'- chlorophenyl)urea (Triclocarban®) or 3,7,1 1 -trimethyldodeca-2, 5,10-trienol (Farnesol®); quaternary ammonium salts such as cetyltrimethylammonium salts or cetylpyridinium salts.
- Triclosan® 2,4,4'-trichloro-2'-hydroxydiphenyl ether
- 2,4-dichloro-2'- hydroxydiphenyl ether 2,4-dichloro-2'- hydroxydiphenyl ether
- zinc salts such as zinc salicylate, zinc sulfate, zinc chloride, zinc lactate and zinc phenolsulfonate; chlorhexidine and the salts; diglycerol monocaprate, diglycerol monolaurate, glycerol monolaurate; and polyhexamethylene biguanide salts.
- the deodorant active agents may be present in the composition according to the invention in a proportion from about 0.001 % to 40% by weight and preferably in a proportion of from about 0.1 % to 25% by weight relative to the total composition.
- some of the active agents mentioned above may be incorporated into spherules, especially ionic or nonionic vesicles and/or nanoparticles (nanocapsules and/or nanospheres).
- compositions according to the invention may contain at least one water- immiscible organic liquid phase, known as a fatty phase.
- This phase generally comprises one or more hydrophobic compounds that render the said phase water- immiscible.
- the said phase is liquid (in the absence of structuring agent) at room temperature (20-25°C).
- the water-immiscible organic liquid phase in accordance with the invention is generally constituted of at least one volatile oil and/or one non-volatile oil and optionally at least one structuring agent.
- oil means a fatty substance that is liquid at room temperature (25°C) and atmospheric pressure (760 mmHg, i.e. 10 5 Pa).
- the oil may be volatile or non-volatile.
- the oil may be chosen from any physiologically acceptable oil and in particular cosmetically acceptable oil, especially mineral, animal, plant or synthetic oils; in particular volatile or non-volatile hydrocarbon-based oils and/or silicone oils and/or fluoro oils, and mixtures thereof.
- hydrocarbon-based oil means an oil mainly comprising carbon and hydrogen atoms and optionally one or more functional groups chosen from hydroxyl, ester, ether and carboxylic functional groups.
- the oil has a viscosity of from 0.5 to 100 000 mPa.s, preferably from 50 to 50 000 mPa.s and more preferably from 100 to 30 000 mPa.s.
- volatile oils that may be used in the invention, mention may be made of:
- volatile silicones for instance volatile linear or cyclic silicone oils, especially those with a viscosity ⁇ 8 centistokes (8x10 "6 m 2 /s) and especially containing from 2 to 7 silicon atoms, these silicones optionally comprising alkyl or alkoxy groups containing from 1 to 10 carbon atoms.
- volatile silicone oils that may be used in the invention, mention may be made especially of octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, heptamethyl- hexyltrisiloxane, heptamethyloctyltrisiloxane, hexamethyldisiloxane, octamethyl- trisiloxane, decamethyltetrasiloxane or dodecamethylpentasiloxane;
- R represents an alkyl group comprising from 2 to 4 carbon atoms, one or more hydrogen atoms of which can be replaced by a fluorine or chlorine atom.
- non-volatile oils that may be used in the invention, mention may be made of:
- hydrocarbon-based plant oils such as liquid triglycerides of fatty acids having 4 to 24 carbon atoms, for instance heptanoic or octanoic acid triglycerides, or else wheatgerm oil, olive oil, sweet almond oil, palm oil, rapeseed oil, cottonseed oil, alfalfa oil, poppyseed oil, pumpkin oil, marrow oil, blackcurrant oil, evening primrose oil, millet oil, barley oil, quinoa oil, rye oil, safflower oil, candlenut oil, passion flower oil, musk rose oil, sunflower oil, corn oil, soybean oil, marrow oil, grapeseed oil, sesame seed oil, hazelnut oil, apricot oil, macadamia oil, castor oil, avocado oil, caprylic/capric acid triglycerides, for instance those sold by the company Stearineries Dubois or those sold under the names Miglyol 810, 812 and 818 by the company
- - synthetic esters especially of fatty acids, for instance the oils of formula R1COOR2 in which Ri represents a linear or branched higher fatty acid residue containing from 1 to 40 carbon atoms and R2 represents a hydrocarbon-based chain, which is especially branched, containing from 1 to 40 carbon atoms, with Ri + R 2 > 10, for instance purcellin oil (cetostearyl octanoate), isononyl isononanoate, isopropyl myristate, isopropyl palmitate, C12-C15 alkyl benzoates, hexyl laurate, diisopropyl adipate, isononyl isononanoate, 2-ethylhexyl palmitate, 2-octyldodecyl stearate, 2-octyldodecyl erucate, isostearyl isostearate or tridecyl trimellitate; alcohol or polyalcohol oct
- - fatty alcohols that are liquid at room temperature, containing a branched and/or unsaturated carbon-based chain containing from 12 to 26 carbon atoms, for instance octyldodecanol, isostearyl alcohol, 2-butyloctanol, 2-hexyldecanol, 2- undecylpentadecanol or oleyl alcohol;
- silicone-based oils for instance non-volatile linear or cyclic polydimethylsiloxanes (PDMSs); polydimethylsiloxanes comprising alkyl, alkoxy or phenyl groups, which are pendent or at the end of a silicone-based chain, these groups containing from 2 to 24 carbon atoms; phenyl silicones, for instance phenyl trimethicones, phenyl dimethicones, phenyl trimethylsiloxy diphenyl siloxanes, diphenyl dimethicones, diphenyl methyldiphenyl trisiloxanes and 2- phenylethyl trimethylsiloxy silicates, and
- compositions according to the invention comprising a fatty phase may also contain at least one agent for structuring the said fatty phase, which may preferably be chosen from waxes, pasty compounds, and mineral or organic lipophilic gelling agents, and mixtures thereof. It is understood that the amount of these compounds may be adjusted by a person skilled in the art so as not to harm the effect desired in the context of the present invention.
- Wax(es) may be chosen from waxes, pasty compounds, and mineral or organic lipophilic gelling agents, and mixtures thereof. It is understood that the amount of these compounds may be adjusted by a person skilled in the art so as not to harm the effect desired in the context of the present invention.
- the wax is in general a lipophilic compound that is solid at room temperature (25°C), with a reversible solid/liquid change in state, having a melting point of greater than or equal to 30°C, which may be up to 200°C and in particular up to 120°C.
- the waxes suitable for the invention can exhibit a melting point of greater than or equal to 45°C and in particular of greater than or equal to 55°C.
- the melting point corresponds to the temperature of the most endothermic peak observed in thermal analysis (DSC) as described in Standard ISO 1 1357-3; 1999.
- the melting point of the wax may be measured using a differential scanning calorimeter (DSC), for example the calorimeter sold under the name MDSC 2920® by the company TA Instruments.
- the waxes that may be used in the compositions according to the invention are chosen from waxes that are solid at room temperature of animal, plant, mineral or synthetic origin, and mixtures thereof.
- waxes that are suitable for the invention, mention may be made especially of hydrocarbon-based waxes, for instance beeswax, lanolin wax, Chinese insect waxes, rice bran wax, carnauba wax, candelilla wax, ouricury wax, esparto grass wax, berry wax, shellac wax, Japan wax and sumach wax; montan wax, orange wax and lemon wax, refined sunflower wax sold under the name Sunflower Wax® by Koster Keunen, microcrystalline waxes, paraffins and ozokerite; polyethylene waxes, the waxes obtained by Fischer-Tropsch synthesis and waxy copolymers, and also esters thereof.
- hydrocarbon-based waxes for instance beeswax, lanolin wax, Chinese insect waxes, rice bran wax, carnauba wax, candelilla wax, ouricury wax, esparto grass wax, berry wax, shellac wax, Japan wax and sumach wax
- montan wax, orange wax and lemon wax
- Mention may also be made of waxes obtained by catalytic hydrogenation of animal or plant oils containing linear or branched C8-C32 fatty chains. Mention may especially be made, among these waxes, of isomerized jojoba oil such as the trans-isomerized partially hydrogenated jojoba oil manufactured or sold by the company Desert Whale under the commercial reference lso-Jojoba-50®, hydrogenated sunflower oil, hydrogenated castor oil, hydrogenated coconut oil, hydrogenated lanolin oil and bis(1 ,1 ,1 -trimethylolpropane) tetrastearate sold under the name Hest 2T-4S® by the company Heterene.
- isomerized jojoba oil such as the trans-isomerized partially hydrogenated jojoba oil manufactured or sold by the company Desert Whale under the commercial reference lso-Jojoba-50®, hydrogenated sunflower oil, hydrogenated castor oil, hydrogenated coconut oil, hydrogenated lanolin oil and bis(1 ,1 ,1
- silicone waxes C3o -4 5 alkyl dimethicone
- fluoro waxes C3o -4 5 alkyl dimethicone
- microwaxes that may be used in the compositions according to the invention, mention may be made especially of carnauba microwaxes, such as the product sold under the name MicroCare 350® by the company Micro Powders, synthetic microwaxes, such as the product sold under the name MicroEase 1 14S® by the company Micro Powders, microwaxes consisting of a mixture of carnauba wax and polyethylene wax, such as the products sold under the names Micro Care 300® and 310® by the company Micro Powders, microwaxes consisting of a mixture of carnauba wax and of synthetic wax, such as the product sold under the name Micro Care 325® by the company Micro Powders, polyethylene microwaxes, such as the products sold under the names Micropoly 200®, 220®, 220L® and 250S® by the company Micro Powders, the commercial products Performalene 400 Polyethylene® and Performalene 500-L Polyethylene® from New Phase Technologies, Performalene 655 Polyethylene or paraffin waxes, for instance the wax having the INCI
- composition according to the invention will preferably comprise a content of wax(es) ranging from 3% to 20% by weight relative to the total weight of the composition, in particular from 5% to 15% and more particularly from 6% to 15%.
- anhydrous solid compositions in stick form use will be made of polyethylene microwaxes in the form of crystallites with an aspect ratio at least equal to 2, and with a melting point ranging from 70°C to 1 10°C and preferably from 70°C to 100°C, in order to reduce or indeed even eliminate the presence of strata in the solid composition.
- the polymeric organic lipophilic gelling agents are, for example, partially or totally crosslinked elastomeric organopolysiloxanes of three-dimensional structure, for instance those sold under the names KSG6®, KSG16® and KSG18® by the company Shin-Etsu, Trefil E-505C® or Trefil E-506C® by the company Dow Corning, Gransil SR-CYC®, SR DMF10®, SR-DC556®, SR 5CYC gel®, SR DMF 10 gel® and SR DC 556 gel® by the company Grant Industries and SF 1204® and JK 1 13® by the company General Electric; ethyl cellulose, for instance the product sold under the name Ethocel® by the company Dow Chemical; galactomannans comprising from one to six and in particular from two to four hydroxyl groups per saccharide, substituted with a saturated or unsaturated alkyl chain, for instance guar gum alkylated with Ci to C6, and in particular Ci to C
- lipophilic gelling agents that may be used in the compositions according to the invention, mention may also be made of fatty acid esters of dextrin, such as dextrin palmitates, especially the products sold under the names Rheopearl TL® or Rheopearl KL® by the company Chiba Flour.
- Silicone polyamides of the polyorganosiloxane type such as those described in documents US-A-5 874 069, US-A-5 919 441 , US-A-6 051 216 and US-A-5 981 680 may also be used. These silicone polymers may belong to the following two families:
- suspension agents may be used, in the present case in hydrophilic (aqueous and/or ethanolic) media. They may be cellulose, xanthan, guar, starch, locust bean or agar agar derivatives.
- A a container comprising an antiperspirant composition as defined previously, (B) at least one propellant and a means for dispensing the said aerosol composition.
- Carbon dioxide, nitrous oxide, nitrogen or compressed air may also be used as propellant.
- the compositions as defined previously and the propellant(s) may be in the same compartment or in different compartments in the aerosol container.
- the concentration of propellant generally varies from 5% to 95% by weight of pressurized composition, and more preferentially from 50% to 85% by weight relative to the total weight of the pressurized composition.
- compositions to be made up preparation method and application conditions
- composition is applied at the centre of each fabric.
- the folded fabrics are placed on a perforated plate and covered with a film of cellophane.
- a colorimetric measurement is taken and an average of three measurements per fabric is determined.
- composition 1 of the invention makes it possible to obtain a more stable coloration of the fabric after 4 washing cycles and then 48 hours of exposure to light.
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL13756376T PL2900335T3 (en) | 2012-09-27 | 2013-08-23 | Process for protecting the colour of a textile material with an oil-in-water emulsion containing a mixture of alkylpolyglycoside and fatty alcohol and an associative nonionic polyurethane polyether |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1259117A FR2995914B1 (en) | 2012-09-27 | 2012-09-27 | METHOD FOR PROTECTING THE COLOR OF A TEXTILE MATERIAL WITH OIL-IN-WATER EMULSION CONTAINING A MIXTURE OF ALKYLPOLYGLYCOSIDE AND ALCOHOL FATTY AND AN ASSOCIATIVE NON-IONIC POLYETHANE POLYETHER |
| US201261712340P | 2012-10-11 | 2012-10-11 | |
| PCT/EP2013/067566 WO2014048647A1 (en) | 2012-09-27 | 2013-08-23 | Process for protecting the colour of a textile material with an oil-in-water emulsion containing a mixture of alkylpolyglycoside and fatty alcohol and an associative nonionic polyurethane polyether |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2900335A1 true EP2900335A1 (en) | 2015-08-05 |
| EP2900335B1 EP2900335B1 (en) | 2017-03-22 |
Family
ID=47257957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP13756376.3A Active EP2900335B1 (en) | 2012-09-27 | 2013-08-23 | Process for protecting the colour of a textile material with an oil-in-water emulsion containing a mixture of alkylpolyglycoside and fatty alcohol and an associative nonionic polyurethane polyether |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2900335B1 (en) |
| BR (1) | BR112015006811B1 (en) |
| ES (1) | ES2625068T3 (en) |
| FR (1) | FR2995914B1 (en) |
| MX (1) | MX361869B (en) |
| PL (1) | PL2900335T3 (en) |
| RU (1) | RU2692849C2 (en) |
| WO (1) | WO2014048647A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116723766A (en) * | 2021-01-13 | 2023-09-08 | 联合利华知识产权控股有限公司 | Benefit agent delivery particles |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19641672A1 (en) * | 1996-10-10 | 1998-04-16 | Beiersdorf Ag | Cosmetic or dermatological preparations based on ethylene oxide-free and propylene oxide-free emulsifiers for the production of microemulsion gels |
| US5925338A (en) * | 1997-01-29 | 1999-07-20 | The Gillette Company | Clear antiperspirant or deodorant gel composition with volatile linear silicone to reduce staining |
| FR2781149B1 (en) * | 1998-07-17 | 2001-09-07 | Oreal | DEODORANT COMPOSITION CONTAINING ALUM SALT |
| FR2807656B1 (en) * | 2000-04-18 | 2002-05-24 | Oreal | ANTITRANSPIRANT COSMETIC COMPOSITION THAT DOES NOT STAIN CLOTHING |
| GB0310767D0 (en) * | 2003-05-10 | 2003-06-18 | Unilever Plc | Stick compositions |
| FR2863490B1 (en) * | 2003-12-16 | 2006-05-19 | Oreal | OIL-IN-WATER EMULSION DEORING COMPOSITION CONTAINING A MIXTURE OF ALKYLPOLYGLYCOSIDE AND FATTY ALCOHOL AND AN ASSOCIATIVE NON-IONIC POLYETHANE POLYETHER |
| US20060115440A1 (en) * | 2004-09-07 | 2006-06-01 | Arata Andrew B | Silver dihydrogen citrate compositions |
-
2012
- 2012-09-27 FR FR1259117A patent/FR2995914B1/en not_active Expired - Fee Related
-
2013
- 2013-08-23 PL PL13756376T patent/PL2900335T3/en unknown
- 2013-08-23 EP EP13756376.3A patent/EP2900335B1/en active Active
- 2013-08-23 RU RU2015115647A patent/RU2692849C2/en active
- 2013-08-23 MX MX2015002028A patent/MX361869B/en active IP Right Grant
- 2013-08-23 WO PCT/EP2013/067566 patent/WO2014048647A1/en not_active Ceased
- 2013-08-23 ES ES13756376.3T patent/ES2625068T3/en active Active
- 2013-08-23 BR BR112015006811A patent/BR112015006811B1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014048647A1 (en) | 2014-04-03 |
| MX361869B (en) | 2018-12-18 |
| PL2900335T3 (en) | 2017-08-31 |
| ES2625068T3 (en) | 2017-07-18 |
| BR112015006811B1 (en) | 2019-08-13 |
| FR2995914B1 (en) | 2016-12-30 |
| MX2015002028A (en) | 2015-06-22 |
| EP2900335B1 (en) | 2017-03-22 |
| BR112015006811A2 (en) | 2018-07-17 |
| RU2015115647A (en) | 2016-11-20 |
| FR2995914A1 (en) | 2014-03-28 |
| RU2692849C2 (en) | 2019-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2358444B1 (en) | Cosmetic method for treating human perspiration using particles of an expanded amorphous mineral material; compositions. | |
| US10117816B2 (en) | Cosmetic process for treating human body odor using a 4-(3-ethoxy-4-hydroxyphenyl)alkyl ketone or 2-ethoxy-4-hydroxyalkylphenol compound | |
| EP2734175B2 (en) | Use, as antiperspirant, of a polyvalent cation salt without aluminium halide antiperspirant or compound capable of reacting with said salt in order to produce an antiperspirant effect | |
| EP2900201B1 (en) | Antiperspirant oil-in-water emulsion comprising an aluminium and/or zirconium antiperspirant salt or complex and a water-insoluble block film-forming ethylenic polymer | |
| EP2854747B1 (en) | Cosmetic composition comprising the combination of a lipophilic salicylic acid derivative, an antiperspirant aluminium salt or complex and an amino acid-n,n-diacetic acid salt | |
| WO2012084520A2 (en) | Use of hydrophobic aerogel particles as deodorant active agent; method for the treatment of human body odours | |
| EP2988827B1 (en) | Cosmetic use of a geraniol-rich essential oil of satureja montana as deodorant active agent | |
| WO2016092107A1 (en) | Deodorant emulsion containing a mixture of alkylpolyglycoside and fatty alcohol, an associative nonionic polyurethane polyether, a volatile hydrocarbon-based oil | |
| EP2900335B1 (en) | Process for protecting the colour of a textile material with an oil-in-water emulsion containing a mixture of alkylpolyglycoside and fatty alcohol and an associative nonionic polyurethane polyether | |
| WO2011157609A2 (en) | Use of amino acid derivatives as agents for treating human perspiration, novel compounds, and compositions containing them | |
| EP4267078B1 (en) | Process for treating human perspiration and body odors using magnesium oxide and a phosphate salt | |
| WO2011047982A2 (en) | Use of adenosine and/or of one of its derivatives as agent for the treatment of human perspiration | |
| EP2642974B1 (en) | Process for treating perspiration using a carbonyl compound capable of reacting via the maillard reaction | |
| WO2011157610A2 (en) | Use of novel amino acid derivatives as agents for treating human perspiration, and compositions containing them | |
| BR112013025119B1 (en) | Cosmetic process for treating human body odors, cosmetic use and composition. | |
| WO2011157612A2 (en) | Amino acid derivatives; compositions containing them; use as agents for treating human perspiration | |
| EP2582354A2 (en) | Amino acid derivatives; compositions containing them; use as agents for treating human perspiration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20150428 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| INTG | Intention to grant announced |
Effective date: 20161007 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 877135 Country of ref document: AT Kind code of ref document: T Effective date: 20170415 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602013018922 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 5 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2625068 Country of ref document: ES Kind code of ref document: T3 Effective date: 20170718 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20170322 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170623 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170622 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 877135 Country of ref document: AT Kind code of ref document: T Effective date: 20170322 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170622 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170724 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170722 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602013018922 Country of ref document: DE |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 |
|
| 26N | No opposition filed |
Effective date: 20180102 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170831 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170831 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
| REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20170831 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170823 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170823 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170831 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170823 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20130823 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170322 |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230527 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PL Payment date: 20250612 Year of fee payment: 13 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20250902 Year of fee payment: 13 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20250702 Year of fee payment: 13 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20250722 Year of fee payment: 13 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20250703 Year of fee payment: 13 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20250703 Year of fee payment: 13 |